MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership
Cannabis Law Report
SEPTEMBER 3, 2019
The state-of-the-art facility will feature supercritical CO 2 extraction capacity to process up to 75,000 kg of dried cannabis annually as well secondary processing equipment for the manufacture of purified and high-concentrate cannabis distillate. Australian Leadership Appointments. in Australia earlier this year. About MediPharm Labs.
Let's personalize your content